AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
EFFICACY OF PYRIDOXINE TO AMELIORATE THE CUTANEOUS TOXICITY ASSOCIATED WITH DOXORUBICIN CONTAINING PEGYLATED (STEALTH) LIPOSOMES - A RANDOMIZED, DOUBLE-BLIND CLINICAL-TRIAL USING A CANINE MODEL
Authors: VAIL DM CHUN R THAMM DH GARRETT LD COOLEY AJ OBRADOVICH JE
Citation: Dm. Vail et al., EFFICACY OF PYRIDOXINE TO AMELIORATE THE CUTANEOUS TOXICITY ASSOCIATED WITH DOXORUBICIN CONTAINING PEGYLATED (STEALTH) LIPOSOMES - A RANDOMIZED, DOUBLE-BLIND CLINICAL-TRIAL USING A CANINE MODEL, Clinical cancer research, 4(6), 1998, pp. 1567-1571
AN ACCELERATED TECHNIQUE FOR IRRADIATION OF MALIGNANT CANINE NASAL AND PARANASAL SINUS TUMORS
Authors: ADAMS WM MILLER PE VAIL DM FORREST LJ MACEWEN EG
Citation: Wm. Adams et al., AN ACCELERATED TECHNIQUE FOR IRRADIATION OF MALIGNANT CANINE NASAL AND PARANASAL SINUS TUMORS, Veterinary radiology & ultrasound, 39(5), 1998, pp. 475-481
FELINE LYMPHOMA (145 CASES) - PROLIFERATION INDEXES, CLUSTER OF DIFFERENTIATION 3 IMMUNOREACTIVITY, AND THEIR ASSOCIATION WITH PROGNOSIS IN90 CATS
Authors: VAIL DM MOORE AS OGILVIE GK VOLK LM
Citation: Dm. Vail et al., FELINE LYMPHOMA (145 CASES) - PROLIFERATION INDEXES, CLUSTER OF DIFFERENTIATION 3 IMMUNOREACTIVITY, AND THEIR ASSOCIATION WITH PROGNOSIS IN90 CATS, Journal of veterinary internal medicine, 12(5), 1998, pp. 349-354
PROGNOSIS FOR DOGS WITH NONLYMPHOMATOUS, SMALL-INTESTINAL TUMORS TREATED BY SURGICAL EXCISION
Authors: CRAWSHAW J BERG J SARDINAS JC ENGLER SJ RAND WM OGILVIE GK SPODNICK GJ OKEEFE DA VAIL DM HENDERSON RA
Citation: J. Crawshaw et al., PROGNOSIS FOR DOGS WITH NONLYMPHOMATOUS, SMALL-INTESTINAL TUMORS TREATED BY SURGICAL EXCISION, The Journal of the American Animal Hospital Association, 34(6), 1998, pp. 451-456
PRECLINICAL EVALUATION OF A STERICALLY STABILIZED LIPOSOME-ENCAPSULATED CISPLATIN IN CLINICALLY NORMAL CATS
Authors: THAMM DH VAIL DM
Citation: Dh. Thamm et Dm. Vail, PRECLINICAL EVALUATION OF A STERICALLY STABILIZED LIPOSOME-ENCAPSULATED CISPLATIN IN CLINICALLY NORMAL CATS, American journal of veterinary research, 59(3), 1998, pp. 286-289
PRECLINICAL TRIAL OF DOXORUBICIN ENTRAPPED IN STERICALLY STABILIZED LIPOSOMES IN DOGS WITH SPONTANEOUSLY ARISING MALIGNANT-TUMORS
Authors: VAIL DM KRAVIS LD COOLEY AJ CHUN R MACEWEN EG
Citation: Dm. Vail et al., PRECLINICAL TRIAL OF DOXORUBICIN ENTRAPPED IN STERICALLY STABILIZED LIPOSOMES IN DOGS WITH SPONTANEOUSLY ARISING MALIGNANT-TUMORS, Cancer chemotherapy and pharmacology, 39(5), 1997, pp. 410-416
ASSESSMENT OF POTENTIAL DOUBLING TIME (T-POT), ARGYROPHILIC NUCLEOLARORGANIZER REGIONS (AGNOR), AND PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AS PREDICTORS OF THERAPY RESPONSE IN CANINE NON-HODGKINS-LYMPHOMA
Authors: VAIL DM KISSEBERTH WC OBRADOVICH JE MOORE FM LONDON CA MACEWEN EG RITTER MA
Citation: Dm. Vail et al., ASSESSMENT OF POTENTIAL DOUBLING TIME (T-POT), ARGYROPHILIC NUCLEOLARORGANIZER REGIONS (AGNOR), AND PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AS PREDICTORS OF THERAPY RESPONSE IN CANINE NON-HODGKINS-LYMPHOMA, Experimental hematology, 24(7), 1996, pp. 807-815
FREQUENCY OF ARGYROPHILIC NUCLEOLAR ORGANIZER REGIONS IN FINE-NEEDLE ASPIRATES AND BIOPSY SPECIMENS FROM MAST-CELL TUMORS IN DOGS
Authors: KRAVIS LD VAIL DM KISSEBERTH WC OGILVIE GK VOLK LM
Citation: Ld. Kravis et al., FREQUENCY OF ARGYROPHILIC NUCLEOLAR ORGANIZER REGIONS IN FINE-NEEDLE ASPIRATES AND BIOPSY SPECIMENS FROM MAST-CELL TUMORS IN DOGS, Journal of the American Veterinary Medical Association, 209(8), 1996, pp. 1418
EVALUATION OF DOGS AND CATS WITH TUMORS OF THE EAR CANAL - 145 CASES (1978-1992)
Authors: LONDON CA DUBILZEIG RR VAIL DM OGILVIE GK HAHN KA BREWER WG HAMMER AS OKEEFE DA CHUN R MCENTEE MC MCCAW DL FOX LE NORRIS AM KLAUSNER JS
Citation: Ca. London et al., EVALUATION OF DOGS AND CATS WITH TUMORS OF THE EAR CANAL - 145 CASES (1978-1992), Journal of the American Veterinary Medical Association, 208(9), 1996, pp. 1413
ADJUVANT THERAPY FOR OSTEOSARCOMA IN DOGS - RESULTS OF RANDOMIZED CLINICAL-TRIALS USING COMBINED LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE AND CISPLATIN
Authors: KURZMAN ID MACEWEN EG ROSENTHAL RC FOX LE KELLER ET HELFAND SC VAIL DM DUBIELZIG RR MADEWELL BR RODRIGUEZ CO OBRADOVICH J FIDEL J ROSENBERG M
Citation: Id. Kurzman et al., ADJUVANT THERAPY FOR OSTEOSARCOMA IN DOGS - RESULTS OF RANDOMIZED CLINICAL-TRIALS USING COMBINED LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE AND CISPLATIN, Clinical cancer research, 1(12), 1995, pp. 1595-1601
LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE ADJUVANT IMMUNOTHERAPY FOR SPLENIC HEMANGIOSARCOMA IN THE DOG - A RANDOMIZED MULTIINSTITUTIONAL CLINICAL-TRIAL
Authors: VAIL DM MACEWEN EG KURZMAN ID DUBIELZIG RR HELFAND SC KISSEBERTH WC LONDON CA OBRADOVICH JE MADEWELL BR RODRIGUEZ CO FIDEL J SUSANECK S ROSENBERG M
Citation: Dm. Vail et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE ADJUVANT IMMUNOTHERAPY FOR SPLENIC HEMANGIOSARCOMA IN THE DOG - A RANDOMIZED MULTIINSTITUTIONAL CLINICAL-TRIAL, Clinical cancer research, 1(10), 1995, pp. 1165-1170
LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY (VOL 10, PG 125, 1995)
Authors: FOX LE MACEWEN EG KURZMAN ID DUBIELZIG RR HEIFAND SC VAIL DM KISSEBERTH W LONDON C MADEWELL BR RODRIGUEZ CO JEGLUM KA ROSENBERG M ROSENTHAL RC
Citation: Le. Fox et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY (VOL 10, PG 125, 1995), Cancer biotherapy, 10(3), 1995, pp. 249-249
LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY
Authors: FOX LE MACEWEN EG KURZMAN ID DUBIELZIG RR HELFAND SC VAIL DM KISSEBERTH W LONDON C MADEWELL BR RODRIGUEZ CO JEGLUM KA ROSENBERG M ROSENTHAL RC
Citation: Le. Fox et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY, Cancer biotherapy, 10(2), 1995, pp. 125-130
RESPONSE TO LIPOSOME-ENCAPSULATED DOXORUBICIN (TLC D-99) IN A DOG WITH MYELOMA
Authors: KISSEBERTH WC MACEWEN EG HELFAND SC VAIL DM LONDON CL KELLER E
Citation: Wc. Kisseberth et al., RESPONSE TO LIPOSOME-ENCAPSULATED DOXORUBICIN (TLC D-99) IN A DOG WITH MYELOMA, Journal of veterinary internal medicine, 9(6), 1995, pp. 425-428
DIFFERENTIAL CELL ANALYSIS AND PHENOTYPIC SUBTYPING OF LYMPHOCYTES INBRONCHOALVEOLAR LAVAGE FLUID FROM CLINICALLY NORMAL DOGS
Authors: VAIL DM MAHLER PA SOERGEL SA
Citation: Dm. Vail et al., DIFFERENTIAL CELL ANALYSIS AND PHENOTYPIC SUBTYPING OF LYMPHOCYTES INBRONCHOALVEOLAR LAVAGE FLUID FROM CLINICALLY NORMAL DOGS, American journal of veterinary research, 56(3), 1995, pp. 282-285
ACTINOMYCIN-D FOR REINDUCTION OF REMISSION IN DOGS WITH RESISTANT LYMPHOMA
Authors: MOORE AS OGILVIE GK VAIL DM
Citation: As. Moore et al., ACTINOMYCIN-D FOR REINDUCTION OF REMISSION IN DOGS WITH RESISTANT LYMPHOMA, Journal of veterinary internal medicine, 8(5), 1994, pp. 343-344
THYROID-HORMONE CONCENTRATIONS IN DOGS WITH CHRONIC WEIGHT-LOSS, WITHSPECIAL REFERENCE TO CANCER CACHEXIA
Authors: VAIL DM PANCIERA DL OGILVIE GK
Citation: Dm. Vail et al., THYROID-HORMONE CONCENTRATIONS IN DOGS WITH CHRONIC WEIGHT-LOSS, WITHSPECIAL REFERENCE TO CANCER CACHEXIA, Journal of veterinary internal medicine, 8(2), 1994, pp. 122-127
ALTERATIONS IN LIPOPROTEIN PROFILES IN DOGS WITH LYMPHOMA
Authors: OGILVIE GK FORD RB VAIL DM WALTERS LM SALMAN MD BABINEAU C FETTMAN MJ
Citation: Gk. Ogilvie et al., ALTERATIONS IN LIPOPROTEIN PROFILES IN DOGS WITH LYMPHOMA, Journal of veterinary internal medicine, 8(1), 1994, pp. 62-66
EVALUATION OF PROGNOSTIC FACTORS FOR DOGS WITH SYNOVIAL SARCOMA - 36 CASES (1986-1991)
Authors: VAIL DM POWERS BE GETZY DM MORRISON WB MCENTEE MC OKEEFE DA NORRIS AM WITHROW SJ
Citation: Dm. Vail et al., EVALUATION OF PROGNOSTIC FACTORS FOR DOGS WITH SYNOVIAL SARCOMA - 36 CASES (1986-1991), Journal of the American Veterinary Medical Association, 205(9), 1994, pp. 1300-1307
EVALUATION OF PROGNOSTIC FACTORS FOR DOGS WITH SYNOVIAL SARCOMA - 36 CASES (1986-1991)
Authors: VAIL DM POWERS BE GETZY DM MORRISON WB MCENTEE MC OKEEFE DA NORRIS AM WITHROW SJ
Citation: Dm. Vail et al., EVALUATION OF PROGNOSTIC FACTORS FOR DOGS WITH SYNOVIAL SARCOMA - 36 CASES (1986-1991), Journal of the American Veterinary Medical Association, 205(9), 1994, pp. 1300-1307
PHARMACOKINETICS AND SHORT-TERM CLINICOPATHOLOGICAL CHANGES AFTER INTRAVENOUS ADMINISTRATION OF A HIGH-DOSE OF METHIMAZOLE IN DOGS
Authors: VAIL DM ELFARRA AA PANCIERA DL HUTSON PR
Citation: Dm. Vail et al., PHARMACOKINETICS AND SHORT-TERM CLINICOPATHOLOGICAL CHANGES AFTER INTRAVENOUS ADMINISTRATION OF A HIGH-DOSE OF METHIMAZOLE IN DOGS, American journal of veterinary research, 55(11), 1994, pp. 1597-1601
PHARMACOKINETICS AND SHORT-TERM CLINICOPATHOLOGICAL CHANGES AFTER INTRAVENOUS ADMINISTRATION OF A HIGH-DOSE OF METHIMAZOLE IN DOGS
Authors: VAIL DM ELFARRA AA PANCIERA DL HUTSON PR
Citation: Dm. Vail et al., PHARMACOKINETICS AND SHORT-TERM CLINICOPATHOLOGICAL CHANGES AFTER INTRAVENOUS ADMINISTRATION OF A HIGH-DOSE OF METHIMAZOLE IN DOGS, American journal of veterinary research, 55(11), 1994, pp. 1597-1601
METHIMAZOLE AS A PROTECTANT AGAINST CISPLATIN-INDUCED NEPHROTOXICITY USING THE DOG AS A MODEL
Authors: VAIL DM ELFARRA AA COOLEY AJ PANCIERA DL MACEWEN EG SOERGEL SA
Citation: Dm. Vail et al., METHIMAZOLE AS A PROTECTANT AGAINST CISPLATIN-INDUCED NEPHROTOXICITY USING THE DOG AS A MODEL, Cancer chemotherapy and pharmacology, 33(1), 1993, pp. 25-30
NUTRITIONAL MANAGEMENT OF CATS WITH INFECTIOUS-DISEASE
Authors: JACKSON MW VAIL DM
Citation: Mw. Jackson et Dm. Vail, NUTRITIONAL MANAGEMENT OF CATS WITH INFECTIOUS-DISEASE, The Veterinary clinics of North America. Small animal practice, 23(1), 1993, pp. 155-171
RECENT ADVANCES IN CHEMOTHERAPY FOR LYMPHOMA OF DOGS AND CATS
Authors: VAIL DM
Citation: Dm. Vail, RECENT ADVANCES IN CHEMOTHERAPY FOR LYMPHOMA OF DOGS AND CATS, The Compendium on continuing education for the practicing veterinarian, 15(8), 1993, pp. 1031
Risultati: 1-25 | 26-26